Recurrent Head and Neck Squamous Cell Carcinoma

specific

The reemergence of squamous cell carcinoma in the head and neck region after a period of remission.

63

Centers

122

Active Trials

$2M

Cancer Funding

Top Centers for Recurrent Head and Neck Squamous Cell Carcinoma(63)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
72.0
2
High-Volume Research Center
72.0
3
NCI Comprehensive
High-Volume Research Center
70.2
4
NCI Clinical
High-Volume Research Center
70.2
5
High-Volume Research Center
70.2
668.5
7
NCI Comprehensive
Active Research Program
68.5
8
NCI Comprehensive
Active Research Program
64.2
9
NCI Comprehensive
Active Research Program
64.2
10
NCI Comprehensive
Active Research Program
64.2
11
NCI Comprehensive
Active Research Program
64.2
12
NCI Comprehensive
Active Research Program
64.2
13
NCI Comprehensive
Active Research Program
64.2
14
NCI Comprehensive
Active Research Program
64.2
15
NCI Comprehensive
Active Research Program
64.2
16
Active Research Program
64.2
17
Active Research Program
64.2
18
NCI Comprehensive
Active Research Program
58.0
19
NCI Comprehensive
Active Research Program
57.5
20
NCI Comprehensive
Active Research Program
55.6
21
NCI Comprehensive
Active Research Program
55.6
22
NCI Comprehensive
Active Research Program
55.6
23
NCI Comprehensive
Active Research Program
55.6
24
NCI Comprehensive
Active Research Program
55.6
25
NCI Comprehensive
Active Research Program
55.6
26
NCI Comprehensive
Active Research Program
55.6
27
Active Research Program
55.6
28
NCI Comprehensive
Active Research Program
55.6
29
NCI Comprehensive
Active Research Program
55.6
30
NCI Comprehensive
Active Research Program
55.6
31
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
55.6
32
Active Research Program
55.6
33
Active Research Program
55.6
34
NCI Comprehensive
Active Research Program
40.2
35
NCI Comprehensive
Active Research Program
40.2
36
NCI Comprehensive
Active Research Program
40.2
37
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
40.2
38
NCI Comprehensive
Active Research Program
40.2
39
NCI Comprehensive
Active Research Program
40.2
40
NCI Comprehensive
Active Research Program
40.2
41
NCI Clinical
Active Research Program
40.2
42
NCI Comprehensive
Active Research Program
40.2
43
NCI Comprehensive
Active Research Program
40.2
44
NCI Comprehensive
Active Research Program
40.2
45
Active Research Program
40.2
46
NCI Clinical
Active Research Program
40.2
47
Active Research Program
40.2
48
NCI Clinical
Active Research Program
40.2
49
NCI Clinical
Active Research Program
40.2
50
NCI Comprehensive
Active Research Program
40.2
51
Active Research Program
40.2
52
Active Research Program
40.2
53
Active Research Program
40.2
54
Active Research Program
40.2
55
Active Research Program
40.2
56
Active Research Program
40.2
57
Active Research Program
40.2
58
Active Research Program
40.2
59
Active Research Program
40.2
60
Active Research Program
40.2
61
NCI Comprehensive
28.8
62
NCI Comprehensive
28.8
63
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
28.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →